An Alternative to Knee Replacement

Yes, Cartistem has an exceptional 14-year safety record. It was officially approved by the South Korean Ministry of Food and Drug Safety in 2012 and has since been successfully used in over 36,000 procedures globally. Our partner hospitals in Seoul are JCI-accredited, the gold standard for international healthcare quality and patient safety. Before you commit to anything, Yuni will personally walk you through the clinical data, success rates, and what to expect during your recovery.

Health Canada classifies advanced stem cell therapies as prescription drugs. Even though a treatment is safe and highly successful overseas, Canadian law prohibits doctors from offering it until it completes extensive, local testing. Cartistem is currently locked behind this slow, rigid regulatory process.

Because Health Canada does not automatically accept international medical data. Even though South Korea has a proven 14-year track record of safety and successful cartilage regrowth since 2012, Canadian regulators classify this as "international real-world evidence" rather than a controlled clinical trial. By law, advanced cell therapies are treated like brand-new prescription drugs. This means the treatment cannot be imported or sold until scientists repeat the entire testing process from scratch inside North American facilities.

Realistically, wide availability in Canada is likely 5 to 10 years away. While a North American Phase 3 trial was approved on paper, North American regulators (like the US FDA and Health Canada) have historically been highly resistant to approving stem cell therapies.

• The Setup Delay: Individual Canadian hospitals must first be selected and approved by local ethics boards before they can even screen a single patient.
• The Tracking Period: Once surgeries finally happen, patients must be monitored for years to track long-term safety.
• The Regulatory Resistance: Because the FDA and Health Canada scrutinize live cell products much harder than standard drugs, any minor paperwork delay or extra safety request can stall the approval process for years.

Current options in Canada are highly limited and mostly manage symptoms rather than fixing the root problem. You can receive basic PRP (Platelet-Rich Plasma) or cortisone injections to temporarily reduce pain, or undergo traditional surgeries like ACI (Autologous Chondrocyte Implantation), which require two separate, invasive surgeries. True, advanced off-the-shelf umbilical cord stem cell therapies like Cartistem are not legally accessible here.

Knee cartilage deteriorates over time, and waiting 5-10 years for Canadian approval could mean your joint becomes too damaged for stem cells to work. By traveling to South Korea, you bypass years of bureaucratic delays. You gain immediate access to a mature medical system where Cartistem is a routine, fully approved procedure. Instead of letting your knee worsen while waiting for Canadian trials to finish, you can start regenerating your cartilage and living pain-free right now.

The price covers hospital and surgery fees, pre-surgery imaging, and any needed medical screening or blood work, the treatment itself, a 5-7 day semi-private or private hospital stay, airport pickup, hospital transfers, Korean-English interpretation, dedicated post-surgical physiotherapy in hospital, and brace, crutches, and medications. Flights are not included. If you want to book a hotel before or after the hospital stay, we can recommend options near the hospital.

This approach is generally considered for people with ICRS Grade III-IV cartilage damage in the knee, between 18 and 70 years of age, with a BMI under 35, and no prior cartilage restoration procedures. During your consultation, Yuni reviews your imaging and medical history with the Korean surgical team to see whether this path makes sense for you.

Most patients plan for 3-4 weeks in total. The procedure itself is minimally invasive and typically takes 1-2 hours. The first two weeks focus on supervised recovery and physiotherapy. By week three, most patients are mobile enough to travel home comfortably.

Not at all. Yuni is fluent in both English and Korean, and our team provides translation throughout - from surgeon consultations to in-hospital communication and discharge instructions.

Before you leave Korea, you will receive a full discharge package translated into English for your Canadian GP or physiotherapist. Yuni coordinates a recovery protocol and can connect you with Canadian physiotherapy resources. We remain your point of contact for any follow-up questions during recovery.

No. Provincial health plans do not cover procedures performed outside Canada, and OHIP specifically eliminated out-of-country emergency coverage in 2020. The full cost of the procedure, any complications, and post-operative care in South Korea is your responsibility. We strongly recommend purchasing comprehensive travel health insurance before departure. We include this disclosure in our patient agreement and are happy to help you understand your coverage options.

Book a free 30-minute video consultation with Yuni. She will review your situation, answer your questions honestly, and explain the next steps with no pressure.

No, because a 2 to 5-year window is the absolute best-case scenario, and many microfractures fail almost immediately.

While some patients hope to buy time with a free Canadian microfracture, clinical data shows a highly unpredictable success rate. Because this procedure forces your body to grow weak, fibrous scar tissue instead of real cartilage, it frequently fails within the very first 12 to 24 months.

Taking the "free" path carries severe, hidden risks to your long-term mobility:

• Immediate Failure Risk: If your body fails to generate enough scar tissue, or if that tissue tears under daily walking weight, the surgery fails instantly, leaving you in chronic pain.
• Permanent Bone Damage: Microfracture requires drilling physical holes into your knee bone. If the surgery fails, it leaves behind a scarred, compromised bone structure that makes future regenerative treatments more difficult.
• Accelerated Joint Breakdown: Walking on weak scar tissue causes uneven friction inside your joint. This rapidly destroys your remaining healthy cartilage, pushing you much faster toward a total knee replacement.
• You Can Still Get Cartistem Later, But It's Not Ideal: If you have already had a failed microfracture, South Korean surgeons can clean out the old scar tissue and perform Cartistem. However, it is always medically superior to treat a native, undamaged bone structure before it undergoes drilling.
• The Bottom Line: A failed microfracture is not a neutral event. It actively worsens your knee joint, wastes months on failed rehabilitation, and narrows your window of eligibility for advanced stem cell repair. Fixing it right the first time with Cartistem in South Korea is a permanent investment in your health.